Among them, an overlap has been found between genetic risk factors for AD and severe COVID-19, such as single-nucleotide polymorphisms (SNPs) in oligoadenylate synthetase 1 (OAS1) [132] and bridging integrator 1 (BIN1) genes [133]. This evidence concerns the gene OAS1 and Alzheimer disease.